Joseph H. Wender, Director at IONIS PHARMACEUTICALS INC (IONS), sold 44,800 shares at $75.16 ($3.3M) on 2025-10-31, disclosed to the SEC on 2025-11-03.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.19 | 2,484 | $179K | 5.4% |
| 2 | $72.19 | 2,484 | $179K | 5.4% |
| 3 | $73.16 | 8,341 | $610K | 18.5% |
| 4 | $73.16 | 8,341 | $610K | 18.5% |
| 5 | $73.85 | 5,975 | $441K | 13.4% |
| 6 | $73.85 | 5,975 |
| $441K |
| 13.4% |
| 7 | $75.16 | 11,200 | $842K | 25.5% |
| Total | $73.74 avg | 44,800 | $3.3M | 100% |
| Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |
| IONS | SELL | 2018-05-11 | $1.3M | — | Filing → |